These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 32538776

  • 21. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Xie P, Luo M, Deng X, Fan J, Xiong L.
    Nutrients; 2023 Sep 04; 15(17):. PubMed ID: 37686889
    [Abstract] [Full Text] [Related]

  • 22. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Shanshal SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN.
    Ceska Slov Farm; 2024 Sep 04; 73(1):233-241. PubMed ID: 38185646
    [Abstract] [Full Text] [Related]

  • 23. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Shanshal SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN.
    Ceska Slov Farm; 2024 Sep 04; 72(5):233-241. PubMed ID: 38195431
    [Abstract] [Full Text] [Related]

  • 24. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
    Yoon JY, Cha JM, Oh JK, Tan PL, Kim SH, Kwak MS, Jeon JW, Shin HP.
    Dig Dis Sci; 2018 Oct 04; 63(10):2754-2764. PubMed ID: 29876777
    [Abstract] [Full Text] [Related]

  • 25. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y.
    J Clin Gastroenterol; 2011 Jul 04; 45(6):518-25. PubMed ID: 21436726
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
    Konstantis G, Efstathiou S, Pourzitaki C, Kitsikidou E, Germanidis G, Chourdakis M.
    Clin Nutr; 2023 May 04; 42(5):800-809. PubMed ID: 37031468
    [Abstract] [Full Text] [Related]

  • 27. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S.
    Nutrition; 2014 Oct 04; 30(10):1151-7. PubMed ID: 25194614
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.
    Am J Gastroenterol; 2006 Jul 04; 101(7):1581-90. PubMed ID: 16863564
    [Abstract] [Full Text] [Related]

  • 29. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome.
    Hong KS, Kang HW, Im JP, Ji GE, Kim SG, Jung HC, Song IS, Kim JS.
    Gut Liver; 2009 Jun 04; 3(2):101-7. PubMed ID: 20431731
    [Abstract] [Full Text] [Related]

  • 30. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis.
    Ortiz-Lucas M, Tobías A, Saz P, Sebastián JJ.
    Rev Esp Enferm Dig; 2013 Jan 04; 105(1):19-36. PubMed ID: 23548007
    [Abstract] [Full Text] [Related]

  • 31. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
    Diaz Ferrer J, Parra V, Bendaño T, Montes P, Solorzano P.
    Rev Gastroenterol Peru; 2012 Jan 04; 32(4):387-93. PubMed ID: 23307089
    [Abstract] [Full Text] [Related]

  • 32. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Jan 04; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 33. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
    Hod K, Dekel R, Aviv Cohen N, Sperber A, Ron Y, Boaz M, Berliner S, Maharshak N.
    Neurogastroenterol Motil; 2018 Dec 04; 30(12):e13456. PubMed ID: 30136337
    [Abstract] [Full Text] [Related]

  • 34. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S.
    Benef Microbes; 2018 Sep 18; 9(5):697-706. PubMed ID: 29888656
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK, Maity C.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e23641. PubMed ID: 33545934
    [Abstract] [Full Text] [Related]

  • 36. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, Serra J.
    World J Gastroenterol; 2014 Jul 14; 20(26):8709-16. PubMed ID: 25024629
    [Abstract] [Full Text] [Related]

  • 37. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K, Korpela R.
    Asia Pac J Clin Nutr; 2006 Jul 14; 15(4):576-80. PubMed ID: 17077079
    [Abstract] [Full Text] [Related]

  • 38. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon H, Park YS, Lee DH, Seo JG, Shin CM, Kim N.
    J Clin Biochem Nutr; 2015 Sep 14; 57(2):129-34. PubMed ID: 26388670
    [Abstract] [Full Text] [Related]

  • 39. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K.
    Probiotics Antimicrob Proteins; 2019 Jun 14; 11(2):627-634. PubMed ID: 29508268
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC.
    Gastroenterology; 2023 Nov 14; 165(5):1206-1218. PubMed ID: 37541528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.